Ren, Yong

Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells

Jiang, H., Ren, Y., Yuen, E. Y., Zhong, P., Ghaedi, M., Hu, Z., Azabdaftari, G., Nakaso, K., Yan, Z., & Feng, J. (2012) · Nature Communications

Parkinson's Disease Mechanisms and TreatmentsPluripotent Stem Cells Research

Cited by 254

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis

Jiang, H., Ren, Y., Zhao, J., & Feng, J. (2004) · Human Molecular Genetics

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 239

Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons

Ren, Y., Jiang, H., Hu, Z., Fan, K., Wang, J., Janoschka, S., Wang, X., Ge, S., & Feng, J. (2015) · Stem Cells

Parkinson's Disease Mechanisms and TreatmentsPluripotent Stem Cells Research

Cited by 109

Rotenone selectively kills serotonergic neurons through a microtubule‐dependent mechanism

Ren, Y., & Feng, J. (2007) · Journal of Neurochemistry

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 65

Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons

Saleem, K., Xiao, Z., Zhu, B., Ren, Y., Yan, Z., & Feng, J. (2026) · Molecular Psychiatry

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 10